Utilidad clínica y valor pronóstico de los niveles de leptina, su receptor soluble y grelina en pacientes con insuficiencia cardiaca en presencia o ausencia de obesidad

Rodríguez-Artalejo, 2004, Epidemiología de la insuficiencia cardiaca, Rev Esp Cardiol, 57, 163, 10.1157/13057268 McMurray, 1998, Clinical epidemiology of heart failure: public and private health burden, Eur Heart J, 19, P9 Rodríguez-Artalejo, 1997, Trends in hospitalization and mortality for heart failure in Spain, 1980-1993, Eur Heart J, 18, 1771, 10.1093/oxfordjournals.eurheartj.a015172 McCullough, 2002, Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) Study, J Am Coll Cardiol, 39, 60, 10.1016/S0735-1097(01)01700-4 Pecker M, Cohn JN, eds. Consensus recommendations for the management of chronic heart failure. AM J Cardiol 1999;83: Suppl 1A-38A. Vantrimport, 1998, Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study, Eur Heart J, 19, 1552, 10.1053/euhj.1998.1093 Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD investigators. N Engl J Med 1991;325:293–302. Pfeffer, 2003, Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme, Lancet, 362, 759, 10.1016/S0140-6736(03)14282-1 Granger, 2003, Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial, Lancet, 362, 772, 10.1016/S0140-6736(03)14284-5 McMurray, 2003, Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial, Lancet, 362, 767, 10.1016/S0140-6736(03)14283-3 Packer, 2002, Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study, Circulation, 106, 2194, 10.1161/01.CIR.0000035653.72855.BF The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353:9–13. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart failure (MERIT-HF). Lancet. 1999;353:2001–7. Tamargo, 2004, Bases y evidencias clínicas de los efectos de los nuevos tratamientos farmacológicos en la insuficiencia cardíaca, Rev Esp Cardiol, 57, 447, 10.1157/13061122 Stewart, 2001, More «malignant» than cancer? Five-year survival following a first admission for heart failure, Eur Heart J, 3, 315, 10.1016/S1388-9842(00)00141-0 O’Connell, 1994, Economic impact of heart failure in the United States: a time for a different approach, J Heart Lung Transplant, 13, S107 Navarro López, 1997, Guías para el diagnóstico, clasificación y tratamiento de la insuficiencia cardíaca y del shock, Rev Esp Cardiol, 50, 1 Remme, 2001, Guidelines for the diagnosis and treatment of chronic heart failure, Eur Heart J, 22, 1527, 10.1053/euhj.2001.2783 Hunt, 2001, ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult, J Am Coll Cardiol, 38, 2101, 10.1016/S0735-1097(01)01683-7 Nohria, 2002, Medical management of advanced heart failure, JAMA, 287, 628, 10.1001/jama.287.5.628 Stevenson, 1989, The limited reliability of physical signs for estimating hemodynamics in chronic heart failure, JAMA, 261, 884, 10.1001/jama.1989.03420060100040 Badgett, 1997, Can the clinical examination diagnose left-sided heart failure in adults?, JAMA, 277, 1712, 10.1001/jama.1997.03540450068038 Wolk, 2004, Plasma leptin and prognosis in patients with established coronary atherosclerosis, J Am Coll Cardiol, 44, 1819, 10.1016/j.jacc.2004.07.050 Harvey, 2003, Leptin in the CNS: much more than a satiety signal, Neuropharmacology, 44, 845, 10.1016/S0028-3908(03)00076-5 Tartaglia, 1997, The leptin receptor, J Biol Chem, 272, 6093, 10.1074/jbc.272.10.6093 Tartaglia, 1995, Identification and expression cloning of a leptin receptor, OB-R, Cell, 83, 1263, 10.1016/0092-8674(95)90151-5 Clement, 1998, A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction, Nature, 392, 398, 10.1038/32911 Yildiz, 2004, Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity, Proc Natl Acad Sci U S A, 101, 10434, 10.1073/pnas.0403465101 NIH Publication No. 98-4083. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. NHLBI. Set 1998. Reaven, 2003, The insulin resistance syndrome, Curr Atheroscler Rep, 5, 364, 10.1007/s11883-003-0007-0 Young, 1995, Is noncentral obesity metabolically benign? Implications for prevention from a population survey, JAMA, 274, 1939, 10.1001/jama.1995.03530240049040 Woods, 1998, Signals that regulate food intake and energy homeostasis, Science, 280, 1378, 10.1126/science.280.5368.1378 Lutton, 2002, Cardiomyopathy and myocardial failure, 1829 Nakajima, 1985, Noninvasive study of left ventricular performance in obese patients: influence of duration of obesity, Circulation, 71, 481, 10.1161/01.CIR.71.3.481 Alpert, 1985, Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity, Am J Cardiol, 55, 783, 10.1016/0002-9149(85)90156-0 Messerli, 1983, Dimorphic cardiac adaptation to obesity and arterial hypertension, Ann Intern Med, 99, 757, 10.7326/0003-4819-99-6-757 Drenick, 1980, Excessive mortality and causes of death in morbidly obese men, JAMA, 243, 443, 10.1001/jama.1980.03300310031018 Kenchaiah, 2002, Obesity and the risk of heart failure, N Engl J Med, 347, 305, 10.1056/NEJMoa020245 Mikta, 2002, Peptides prove predictive for heart failure patients, JAMA, 287, 1926, 10.1001/jama.287.15.1926 Remes, 1991, Validity of clinical diagnosis of heart failure in primary health care, Eur Heart J, 12, 315, 10.1093/oxfordjournals.eurheartj.a059896 Wauters, 2000, Human leptin: from an adipocyte hormone to an endocrine mediator, Eur J Endocrinol, 143, 293, 10.1530/eje.0.1430293 Carrascosa, 1999, Leptina: Una hormona del tejido adiposo, Rev Chil, 26, 24 Blum, 1997, Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone, J Clin Endocrinol Metab, 82, 2904, 10.1210/jc.82.9.2904 Hynes, 2001, Leptin and its role in lipid metabolism, Curr Op Lipidol, 12, 321, 10.1097/00041433-200106000-00012 Moschos, 2002, Leptin and reproduction: a review, Fertil Steril, 77, 433, 10.1016/S0015-0282(01)03010-2